Structure-based discovery of dual pathway inhibitors for SARS-CoV-2 entry
Abstract Since 2019, SARS-CoV-2 has evolved rapidly and gained resistance to multiple therapeutics targeting the virus. Development of host-directed antivirals offers broad-spectrum intervention against different variants of concern. Host proteases, TMPRSS2 and CTSL/CTSB cleave the SARS-CoV-2 spike...
Main Authors: | Haofeng Wang, Qi Yang, Xiaoce Liu, Zili Xu, Maolin Shao, Dongxu Li, Yinkai Duan, Jielin Tang, Xianqiang Yu, Yumin Zhang, Aihua Hao, Yajie Wang, Jie Chen, Chenghao Zhu, Luke Guddat, Hongli Chen, Leike Zhang, Xinwen Chen, Biao Jiang, Lei Sun, Zihe Rao, Haitao Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-11-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-023-42527-5 |
Similar Items
-
Conformational Changes in a Macrolide Antibiotic Binding Protein From Mycobacterium smegmatis Upon ADP Binding
by: Qingqing Zhang, et al.
Published: (2021-12-01) -
Identification of serotonin 2A receptor as a novel HCV entry factor by a chemical biology strategy
by: Lin Cao, et al.
Published: (2018-03-01) -
Discovery of the first macrolide antibiotic binding protein in Mycobacterium tuberculosis: a new antibiotic resistance drug target
by: Qingqing Zhang, et al.
Published: (2018-01-01) -
Structural insights into substrate recognition by the type VII secretion system
by: Shuhui Wang, et al.
Published: (2019-11-01) -
Attachment, Entry, and Intracellular Trafficking of Classical Swine Fever Virus
by: Xin Guo, et al.
Published: (2023-09-01)